Thousands of rare diseases have no research program, no trial, no one assigned to them. Orphea pairs tireless AI agents with practicing doctors and scientists to investigate the overlooked — funded by the families, friends, and employers closest to each condition, and published openly and free, forever.
Funding follows scale. A condition affecting a few thousand people worldwide rarely justifies a grant, a trial, or a research team — so the science simply never gets done. The patients are real. The questions are answerable. The work is just unassigned.
The vast majority of rare diseases have no approved therapy — often no active research at all.
Families spend years on a diagnostic odyssey before anyone even names the condition.
Aggregate rare-disease research is a sliver of funding, scattered across thousands of conditions.
AI agents do the relentless reading and connecting; clinicians and scientists decide what's worth pursuing and how. Neither works without the other.
Autonomous agents continuously read the world's literature, patient registries, case reports, and molecular databases — surfacing neglected conditions and the loose threads no one has had time to pull.
Agents synthesize cross-disciplinary evidence into testable hypotheses — repurposed drugs, shared pathways, genetic links — then rank them by plausibility, tractability, and how badly they've been ignored.
A standing board of clinicians and researchers vets every hypothesis, designs the actual study, and partners with the labs and patients who can carry it out. Humans hold the judgment, ethics, and care.
Findings — positive, negative, and inconclusive — are released open-access the moment they're validated, with the data and methods attached so anyone can build on them.
Every published result feeds back into the agents — the more we share, the faster the next discovery.
Funding a condition stands up a dedicated unit — practicing experts and AI agents working as one. The further you fund, the more the team can take on: more clinician hours, more agents in parallel, real labs, real trials.
A practicing physician in the disease area. Sets direction, owns patient care, ethics, and the final call on every study.
Designs and runs the experiments and analyses the agents propose — turning hypotheses into evidence.
Wrangles genomic, molecular, and registry data, and works hand-in-hand with the data agent to find signal.
Keeps the people affected at the center — gathering lived experience and reporting progress back to you.
Reads the entire scientific record without stopping and surfaces what's relevant across every field, for the Clinical Lead.
Connects scattered evidence into testable hypotheses and ranks them by plausibility and how overlooked they are.
Mines molecular and registry datasets for patterns and candidate targets — paired directly with the Data Lead.
Drafts study protocols, simulates outcomes, and flags confounders for the Research Scientist to refine and run.
We don't own the cure. Everyone does. No patents, no paywalls, no embargoes — just the work, in public.
Every paper, dataset, and protocol is free to read and reuse the day it's ready.
We publish what didn't work too. A closed door saves the next team years.
As a non-profit, our only incentive is the science. Discoveries stay in the commons.
Methods, code, and agent reasoning ship alongside results — so others can verify and extend.
Whether you fund the work, do the science, or are living with a condition no one's studying — there's a door for you.
Orphea exists to look. We're funded almost entirely by the people closest to these conditions — families, friends, and employers who decided not to wait for the world to catch up. Sponsor the research into the condition that touched your life.